ANTB
NMRA icon

AMG National Trust Bank’s Neumora Therapeutics NMRA Stock Holding History

AMG National Trust Bank’s Portfolio NMRA Stock Details NMRA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$84.6K Hold
43,379
– – ﹤0.01% 475
2025
Q4 		$77.6K Hold
43,379
– – ﹤0.01% 451
2025
Q3 		$79K Hold
43,379
– – ﹤0.01% 451
2025
Q2 		$31.8K Hold
43,379
– – ﹤0.01% 445
2025
Q1 		$43.4K Hold
43,379
– – ﹤0.01% 440
2024
Q4 		$480K Buy
+43,379
New +$520K 0.01% 344

Other funds holding NMRA

SL
Siren LLC Greenwich, Connecticut $3.61B AUM 203.3% 1-Year Est. Return
SoftBank Group
SoftBank Group Tokyo, Japan $11.4B AUM 27.91% 1-Year Est. Return
PA
Perceptive Advisors New York $5.12B AUM 314.02% 1-Year Est. Return
MCMU
MIC Capital Management (UK) London, United Kingdom $352M AUM 0.23% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
WT
Wellcome Trust London, United Kingdom $9.01B AUM 12.05% 1-Year Est. Return
Millennium Management
Millennium Management New York $240B AUM 35.51% 1-Year Est. Return
IC
Iconiq Capital San Francisco, California $4.46B AUM 22.86% 1-Year Est. Return
LC
Lunate Capital Al Maryah Island, Abu Dhabi, United Arab Emirates $196M AUM 84.21% 1-Year Est. Return

AMG National Trust Bank's NMRA Position: Q1 2026 in Review

AMG National Trust Bank held its Neumora Therapeutics (NMRA) position steady in Q1 2026 at 43,379 shares worth $84.6K. The position accounts for ﹤0.01% of the portfolio, ranked #475.

AMG National Trust Bank first reported a position in NMRA in Q4 2024 and has held it in 6 quarters since. The position peaked at $480K in Q4 2024. 114 funds tracked by Wall St. Rank hold NMRA as of Q1 2026.

  • AMG National Trust Bank held 43,379 shares of Neumora Therapeutics worth $84.6K as of Q1 2026.
  • AMG National Trust Bank left its Neumora Therapeutics share count unchanged in Q1 2026.
  • Neumora Therapeutics made up ﹤0.01% of AMG National Trust Bank's portfolio in Q1 2026, its #475 holding.
  • AMG National Trust Bank first reported a position in Neumora Therapeutics in Q4 2024 and has held it in 6 quarters since.
  • AMG National Trust Bank's Neumora Therapeutics position peaked at $480K in Q4 2024.
  • 114 funds tracked by Wall St. Rank held Neumora Therapeutics as of Q1 2026.

Based on AMG National Trust Bank's 13F filing for Q1 2026, filed 4 May 2026.